California Peptide Research Regulatory Overview
Federal and state regulatory context for research-grade peptide compounds in California. Informational summary for scientific researchers and research institutions.
Disclaimer: This page provides general regulatory context for informational purposes only and does not constitute legal advice. Researchers should consult applicable federal and state regulations and qualified legal counsel before making any decisions based on this content.
Federal Regulatory Context
At the federal level, research-grade peptide compounds used for in vitro research purposes are regulated as research chemicals under FDA jurisdiction. The Controlled Substances Act (CSA) schedules specific compounds with known abuse potential, but the peptide research compounds commonly available through research suppliers, including BPC-157, TB-500, GHK-Cu, NAD+, and Epithalon, are not currently listed under any DEA controlled substance schedule. Federal law requires that research chemicals be sold and used for legitimate research purposes only, consistent with the Research Use Only (RUO) designation applied to these compounds.
California State Context
California does not maintain a separate state analog act or state controlled substance schedule that would impose restrictions on the research-grade peptide compounds commonly used in preclinical laboratory research beyond those imposed by federal law. California Health and Safety Code Section 11000 et seq. establishes the state controlled substance scheduling framework, which mirrors federal scheduling for the compound classes covered. Researchers at California institutions should consult their institutional compliance offices for institution-specific guidance on procurement and use of research chemicals.
Research Overview
California is home to one of the largest concentrations of life science research institutions in the United States, including UC San Diego, UC San Francisco, Stanford, Caltech, and the Salk Institute, all of which operate active preclinical research programs. At the federal level, research-grade peptide compounds used for in vitro laboratory research purposes are governed by FDA regulations for research chemicals and, where applicable, the Controlled Substances Act administered by the DEA. California state law does not impose additional scheduling restrictions on research-grade peptide compounds such as BPC-157, TB-500, GHK-Cu, NAD+, or Epithalon for in vitro laboratory research use. Researchers and institutions in California procuring these compounds should ensure their use is conducted within appropriate institutional research frameworks and compliant with all applicable federal and state laboratory safety regulations.
- •UC San Diego School of Medicine
- •UC San Francisco
- •Stanford University School of Medicine
Commonly Researched Compounds
Research-grade compounds commonly procured by institutions in California for in vitro and preclinical research programs.
Frequently Asked Questions
Legal Disclaimer
The information on this page is provided for general informational and educational purposes only. It does not constitute legal advice and should not be relied upon as such. Laws and regulations governing research chemicals, peptides, and related compounds vary by jurisdiction and are subject to change. Researchers and organizations should consult a qualified legal professional familiar with federal and state law applicable to their specific situation before making any decisions based on this content. Spartan Peptides does not provide legal counsel and makes no representations regarding the legal status of any compound in any specific jurisdiction.
Explore All Research-Grade Compounds
Browse the full Spartan Peptides research compound catalog. All compounds are research-grade, supplied as lyophilized powder with certificate of analysis, for in vitro laboratory research use only.